# Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy

> **NCT03514680** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 226 (actual)

## Conditions studied

- Cancer
- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **BEHAVIORAL:** CIPN Assessment and Management Algorithm

## Key facts

- **NCT ID:** NCT03514680
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-04
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-03-23
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514680, "Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03514680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*